SCHEMBL443989

SCHEMBL443989

[S][C]c1ccccc1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5881404 0.73
SCHEMBL1161988 0.71
SCHEMBL8163 0.71
Diphenylacetylene SCHEMBL29188592 0.69 APP (1.00)
Diphenylacetylene SCHEMBL619305 0.69 APP (0.60)
Diphenylacetylene SCHEMBL68254 0.69 APP (1.00)
Diphenylacetylene SCHEMBL339222 0.69 APP (0.60)
SCHEMBL40533 0.69 APP (0.60)
Diphenylacetylene SCHEMBL960609 0.69 APP (1.00)
SCHEMBL7551334 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113735875-A Preparation method of guaiane sesquiterpene dimer 中国科学院昆明植物研究所 2021-12-03 CN claimed
CN-112300079-A N-difluoromethyl azole selenourea derivative or agriculturally and pharmaceutically acceptable salt and application thereof 华南农业大学 2021-02-02 CN claimed
CN-108892693-B Nucleoside compound, preparation method thereof and pharmaceutical composition for treating flavivirus infection 中国医学科学院医药生物技术研究所 2020-03-10 CN claimed
US-20110028470-A1 Detection and Treatment of Schizophrenia TOKAI UNIVERSITY EDUCATIONAL SYSTEM (JP) 2011-02-03 US claimed
US-20070123577-A1 Inhibitor of protein modification products formation TOKAI UNIVERSITY EDUCATIONAL SYSTEM (JP) 2007-05-31 US claimed
EP-1693369-A1 PROTEIN MODIFIER PRODUCTION INHIBITOR TOKAI UNIVERSITY EDUCATIONAL SYSTEM (JP) 2006-08-23 EP claimed
CN-111196806-B Guanidine derivative and application thereof 广东东阳光药业股份有限公司 2024-04-26 CN disclosed
CN-108892693-B Nucleoside compound, preparation method thereof and pharmaceutical composition for treating flavivirus infection 中国医学科学院医药生物技术研究所 2020-03-10 CN disclosed
CN-104370714-A Preparation method of 2-methylcyclopentadecanon UNIV EAST CHINA NORMAL 2015-02-25 CN disclosed
US-20140335517-A1 DETECTION AND TREATMENT OF SCHIZOPHRENIA RENASCIENCE CO LTD (JP) 2014-11-13 US disclosed
US-8809329-B2 Detection and treatment of schizophrenia TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE (JP) 2014-08-19 US disclosed
US-8723017-B2 Dye sensitised solar cell BASF SE (DE) 2014-05-13 US disclosed
EP-2662453-A2 Detection and treatment of schizophrenia TOKAI UNIVERSITY EDUCATIONAL SYSTEM (JP) 2013-11-13 EP disclosed
US-20110028470-A1 Detection and Treatment of Schizophrenia TOKAI UNIVERSITY EDUCATIONAL SYSTEM (JP) 2011-02-03 US disclosed
EP-2253031-A1 DYE SENSITISED SOLAR CELL BASF SE (DE) 2010-11-24 EP disclosed
EP-2189537-A1 DETECTION AND TREATMENT OF SCHIZOPHRENIA TOKAI UNIVERSITY EDUCATIONAL SYSTEM (JP) 2010-05-26 EP disclosed
US-7645882-B2 Inhibitor of protein modification products formation TOKAI UNIVERSITY EDUCATIONAL SYSTEM (JP) 2010-01-12 US disclosed
WO-2009109499-A1 DYE SENSITISED SOLAR CELL BASF SE (DE) 2009-09-11 WO disclosed
US-20070123577-A1 Inhibitor of protein modification products formation TOKAI UNIVERSITY EDUCATIONAL SYSTEM (JP) 2007-05-31 US disclosed
EP-1693369-A1 PROTEIN MODIFIER PRODUCTION INHIBITOR TOKAI UNIVERSITY EDUCATIONAL SYSTEM (JP) 2006-08-23 EP disclosed